Hamza A. Salim: CTA Collateral Impairment Score Enhances Stroke Prognosis Accuracy
Hamza A. Salim, Post-Doctoral Research Fellow at MD Anderson Cancer Center and Research Collaborator at Johns Hopkins Radiology, has shared a post on X:
”Can a single, simple single-phase CTA score improve stroke outcome prediction?
Our new multicenter study (n=1080), now in JNIS, introduces the CTA Collateral Impairment Score (CCIS): a composite of arterial (Tan) + venous (COVES) collaterals from routine single-phase CTA.
Key findings:
– Favorable outcomes (mRS 0–2): 66% with CCIS 0 vs 17% with CCIS 2
– Mortality: 11% (CCIS 0) vs 36% (CCIS 2)
– CCIS outperformed ASPECTS & occlusion site, and closely matched NIHSS
Many thanks to Dr. Vivek Yedavall for his exceptional mentorship on this project!”
Read the full article here.
Article: Composite arterial and venous collateral score on single-phase CTA predicts 90-day outcomes in anterior circulation large-vessel occlusion stroke
Authors: Hamza Adel Salim, Dhairya A Lakhani, Janet Mei, Manisha Koneru, Aneri Balar, Meisam Hoseinyazdi, Shyam Majmundar, Dylan Wolman, Risheng Xu, Victor Urrutia, Elisabeth B Marsh, Thanh N Nguyen, Judy Huang, David S Liebeskind, Achala Vagal, Adam A Dmytriw, Adrien Guenego, Gregory W Albers, Hanzhang Lu, Kambiz Nael, Argye E Hillis, Rafael Llinas, Max Wintermark, Tobias D Faizy, Jeremy J Heit, Vivek Yedavalli
Stay updated on the latest scientific advances in the field of hematology with Hemostasis Today.
-
Oct 24, 2025, 11:46Rocío Vacik Díaz on Impact of LVAD Implantation at ECTH 2025
-
Oct 23, 2025, 06:03Melanie Daniel: Wonderful Presentation on Emicizumab by Mickael Rosa at ECTH
-
Oct 22, 2025, 06:17We Will Continue to Raise Awareness and Remind Rveryone That Donating Blood Means Saving Lives - Yeolyan Hematology and Oncology Center
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 24, 2025, 11:41Yaping Zhang on Platelet Adhesion Receptors
-
Oct 24, 2025, 11:37Omid Jafari and Colleagues Present the VTE-BERT Natural Language Processing Model
-
Oct 24, 2025, 11:34Insights on IV Thrombolysis and Mechanical Thrombectomy from Benjamin Maier and Colleagues
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize
-
Oct 24, 2025, 10:47Nan van Geloven Was Awarded The Prestigious Vidi Grant
-
Oct 23, 2025, 06:52Louise Bannon: Thrilled to Witness The Incredible Reach of This Year's World Thrombosis Day!
-
Oct 23, 2025, 06:50Caitlin Raymond to Speak at The 11th Annual Bloodless Medicine and Surgery Society Conference